Evidence before treatment

Peptide therapy: evidence, regulation, and safety questions

Understand what peptides are, how evidence differs between compounds, research-only products, FDA approval, compounding, and online provider evaluation.

What should I know about Peptides?

Peptides are chains of amino acids, and some are used in established prescription medicines. Evidence and regulatory status belong to the specific substance, formulation, and use—not to peptides as a class. An experimental or research-only compound should not be treated as proven patient therapy.

Explore the guides

Peptide Certificates of Analysis: What a COA Can and Cannot Show

A certificate of analysis describes particular testing of a particular sample. It does not establish clinical effectiveness, a safe human dose, FDA approval, or that every product bearing a similar name matches the tested material.

Read guide

Animal Peptide Studies vs. Human Evidence: How to Read the Difference

An animal or laboratory study can explore a mechanism, but it does not establish that a peptide benefits people at a safe, effective dose. Look for human evidence for the same substance, formulation, population, and intended outcome before interpreting a research headline as a treatment claim.

Read guide

FDA-Approved, Investigational, and Compounded Peptides: What the Terms Mean

FDA-approved, investigational, and compounded describe different regulatory contexts. An approved medicine has a specific product and indication; investigational treatment is still being studied; a compounded preparation is not FDA-approved before marketing.

Read guide

How to Verify an Online Pharmacy Before Ordering Prescription Medication

Use the state board of pharmacy's official license database to verify the dispensing pharmacy, then confirm its U.S. contact details, prescription requirement, and access to a licensed pharmacist.

Read guide

Can a Peptide Target Cancer? RYZ101 and the ACTION-1 Study

A peptide guides an investigational radioactive therapy to tumor receptors. What the phase 3 ACTION-1 announcement shows—and what remains unanswered.

Read guide

How to Evaluate an Online Peptide Therapy Provider

Questions to ask about clinician credentials, evidence, pharmacy fulfillment, pricing, and follow-up before requesting peptide care online.

Read guide

What Is Sermorelin?

Sermorelin is a growth-hormone secretagogue used in clinician-guided protocols for selected patients.

Read guide

What Is Glutathione?

A grounded overview of glutathione, oxidative stress, route considerations, and safety screening.

Read guide

Peptide Therapy: What Patients Should Know

The practical difference between physician-prescribed peptide therapy and self-sourced research compounds.

Read guide

What Is TB-500?

TB-500 is often discussed alongside recovery protocols. Here is how to think about mechanism, evidence, and safety review.

Read guide

What Is GHK-Cu?

GHK-Cu is a copper peptide discussed in skin and hair-support protocols, with expectations that should stay measured.

Read guide

CJC-1295 / Ipamorelin: What Patients Should Know

Growth-hormone secretagogue protocols require endocrine context, realistic goals, and clinician monitoring.

Read guide

What Is Epitalon?

Epitalon is a small pineal peptide discussed for sleep, circadian rhythm, and healthy aging. Here is what the research shows, and what it does not.

Read guide

What Is SS-31 (Elamipretide)?

SS-31 is a mitochondria-targeted peptide discussed for energy, endurance, and recovery. Here is how it works, what the evidence covers, and who should be careful.

Read guide

How to Think About Compounded Pharmacy Quality

503A and 503B pharmacy language can be confusing. Patients should understand what compounding does and does not mean.

Read guide

What Is Retatrutide?

Retatrutide is a triple-receptor agonist discussed in metabolic research. Availability and appropriateness require careful review.

Read guide

Common Peptides questions

Are all peptides FDA-approved?

No. Some peptide medicines have FDA-approved uses, while other compounds are investigational or have limited human evidence. A product listing, prescription request, laboratory certificate, or mention in a study is not FDA approval.

Does a certificate of analysis prove a peptide works?

No. A certificate may report particular laboratory findings for a sample. It does not establish clinical benefit, an appropriate dose, safety in humans, regulatory approval, or the reliability of every product bearing a similar label.

What should I ask about a proposed peptide treatment?

Ask about the exact substance and formulation, evidence in humans for your intended use, known and uncertain risks, regulatory status, established alternatives, prescriber credentials, pharmacy identity, total cost, and follow-up.

Is research-use-only labeling appropriate for patient treatment?

Research-use-only labeling does not establish that a substance is suitable for human use. Do not interpret seller descriptions, animal findings, or laboratory purity claims as a clinical treatment plan.

Prepare for the next conversation

Use the consultation checklist and cost worksheet to organize your questions. A licensed clinician must determine whether a specific treatment is appropriate.

Primary sources

By the PacificRx editorial team. Educational information, not individualized medical advice.